| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0005 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |